New Anglo/U.S. obesity and cardiometabolic specialist Verdiva Bio Ltd. has launched with a massive $411 million series A and a portfolio of GLP-1 and amylin agonists in-licensed from China. The lead ...
The updated for-purchase World of Glass Database includes worldwide location data for over 200 global float manufacturers as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback